Abstract-This
-dependent Mg 2ϩ transport in vascular smooth muscle cells (VSMCs) from Wistar-Kyoto rats (WKY; nϭ20) and spontaneously hypertensive rats (SHR; nϭ20). Intracellular free concentrations of Mg 2ϩ ([Mg 2ϩ ] i ) and Na ϩ ([Na ϩ ] i ) and intracellular pH (pH i ) were measured with the specific fluorescent probes mag-fura 2-AM, SBFI-AM, and BCECF-AM, respectively. Na ϩ dependency of Mg 2ϩ transport was assessed in Na ϩ -free buffer, and the role of the NHE was determined with the highly selective NHE blocker 5-(N-methyl-N-isobutyl) amiloride (MIA). Basal Key Words: Na ϩ Ⅲ pH Ⅲ signal transduction Ⅲ vascular resistance Ⅲ vasoconstriction Ⅲ magnesium Ⅲ rats, SHR M agnesium has been implicated as an important factor in vascular smooth muscle contraction and blood pressure regulation. [1] [2] [3] Increased concentrations of extracellular Mg 2ϩ cause vasodilation and attenuate agonist-induced constriction, whereas decreased concentrations cause contraction and potentiate agonist-evoked vasoconstriction. 4 -6 The cellular basis for the molecular action of Mg 2ϩ in vasoconstriction is unknown, but Mg 2ϩ probably influences intracellular free calcium concentration ([Ca 2ϩ ] i ), which is a fundamental determinant of myocardial contraction and vascular smooth muscle constriction. Magnesium acts intracellularly as a Ca 2ϩ antagonist [7] [8] [9] or extracellularly by inhibiting transmembrane Ca 2ϩ transport and Ca 2ϩ entry, by decreasing contractile actions of vasoactive agents, and by enhancing relaxant effects of vasodilators. 5, 10, 11 For Mg 2ϩ to significantly modulate intracellular events, Mg 2ϩ itself must be regulated within the cell. Despite the fact that Mg 2ϩ is the most abundant cytosolic divalent cation, 12 19 A similar mechanism has been demonstrated in many cell types, including vascular smooth muscle cells (VSMCs). 14,16,20 -22 Mechanisms that activate the exchanger are unclear, but protein kinase C (PKC) and activation of the Na ϩ -H ϩ antiporter have been implicated. 17, 23, 24 Altered regulation of [Mg 2ϩ ] i may play a role in the pathogenesis of hypertension. The relationship between Mg 2ϩ deficiency and hypertension has been extensively reported. 1, 25, 26 At the cellular level, [Mg 2ϩ ] i is decreased in essential and experimental hypertension. [27] [28] [29] [30] 
Methods

Animal Experiments
The study was approved by the Animal Ethics Committee of the Clinical Research Institute of Montreal. Adult male (17-week-old) WKY (nϭ20) and SHR (nϭ20) (Taconic Farms Inc, Germantown, NY) were studied. Systolic blood pressure was recorded in prewarmed conscious rats by the tail-cuff method with a photoelectric pulse sensor and a polygraph (Grass Instruments Co) a few days before experimentation. Blood pressure was significantly higher (PϽ0.001) in SHR than in WKY (190Ϯ2.1 versus 112Ϯ1.0 mm Hg).
Cell Culture
VSMCs derived from mesenteric arteries, which contribute to peripheral resistance and consequently to blood pressure regulation, were isolated and characterized as described previously. 22, 27, 32 Briefly, mesenteric arteries were cleaned, smooth muscle cells were dissociated by digestion, the tissue was filtered, and the cell suspension was centrifuged and resuspended in DMEM that contained fetal calf serum, L-glutamine, HEPES, penicillin, and streptomycin. VSMCs were grown on round glass coverslips and maintained at 37°C in a humidified incubator. Primary and first-passage cells were studied at subconfluence. Cells were rendered quiescent by serum deprivation for 30 hours before experimentation. 4 , and loaded with mag-fura 2-AM (5 mol/L), which was dissolved in dimethyl sulfoxide with 0.02% pluronic acid. Cells were incubated for 30 minutes at 37°C in a humidified incubator (95% air/5% CO 2 ) and then washed with warmed buffer and incubated for another 15 minutes to ensure complete deesterification. Under these loading conditions, the ratiometric (343 and 380 nm) fluorescence cell images were homogeneous, indicating that there was no significant intracellular compartmentation of mag-fura 2. The coverslip that contained cells was placed in a stainless steel chamber and mounted on the stage of an inverted microscope (Axiovert 135) as previously described. 32 [Mg 2ϩ ] i was measured in multiple cells simultaneously by a fluorescence digital imaging system (Attofluor Ratiovision) with an emission wavelength of 520 nm and alternating excitatory wavelengths of 343 and 380 nm. 37 The Attofluor system was calibrated by viewing mag-fura 2, tetrapotassium salt solutions that contained 0 Mg 2ϩ , and saturating Mg 2ϩ concentrations and including these data in the ratio calculations for construction of a standard curve relating Mg 2ϩ concentration to the 343/380 ratio. The curve was derived from the following equation 38 where R is the ratio of fluorescence at 343 and 380 nm; R max and R min are the ratios for mag-fura-free acid at 343 and 380 nm in the presence of saturating Mg 2ϩ and 0 Mg 2ϩ , respectively; and ␤ is the ratio of fluorescence of mag-fura 2 at 380 nm in 0 and saturating magnesium. K d , the dissociation constant of mag-fura 2 for Mg 2ϩ , is assumed to be 1.5 mmol/L. 37 Video images of fluorescence at 520-nm emission were obtained with an intensified charge-coupled device camera system with the output digitized to a resolution of 512ϫ480 pixels. Images of fluorescence ratios were obtained by dividing, pixel by pixel, the 343-nm image after background subtraction by the 380-nm image after background subtraction. 4 . In the absence of Na ϩ , there was no recovery from this acid load. pH i recovered when the Na ϩ -free solution was replaced with Na ϩ -containing Hanks' buffer solution. This Na ϩ -dependent recovery was inhibited by the Na ϩ -H ϩ exchange blocker 5-(N-methyl-N-isobutyl) amiloride (MIA) (10 Ϫ5 mol/L) 42, 45 and was operationally defined as Na ϩ -H ϩ exchange activity. 43, 44 To quantify the rate of pH i recovery, a straight line was fitted to the initial 60 seconds after the onset of recovery, and the respective slopes were compared. (Figure 1, top) . Ang II induced a dose-dependent reduction in [Mg 2ϩ ] i in WKY and SHR (Figure 1, bottom in SHR (E max ϭ37.5Ϯ1.1 mmol/L) than WKY (E max ϭ 33.7Ϯ1.9 mmol/L) (Figure 1, bottom) . (Figure 4) , suggesting that the Na ϩ -H ϩ exchanger only partially contributes to Ang II-elicited [Na ϩ ] i effects.
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Effects of MIA on Ang II-Induced pH i Responses
To determine whether Ang II activates the Na ϩ -H ϩ exchanger in VSMCs and to assess whether activity of the antiporter is altered in SHR, pH i responses and activity of the Na ϩ -H ϩ exchanger in response to Ang II were determined. Basal pH i was similar in WKY (7.03Ϯ0.21) and SHR (7.06Ϯ0.01). Ang II dose dependently increased pH i ( Figure 5 ). At concentrations Ͼ10 Ϫ9 mol/L, Ang II-induced responses were significantly greater (PϽ0.05) in SHR (E max ϭ7.35Ϯ0.04) than WKY (E max ϭ7.20Ϯ0.01) ( Figure 5 medium caused a rapid decrease in pH i (Figure 6a ). The cells were unable to recover from this acid load in Na ϩ -free buffer. Reintroduction of Na ϩ (with Na ϩ -containing Hanks' buffer solution) resulted in rapid recovery of pH i that approached resting values (Figure 6a and 6b) . This Na ϩ -dependent recovery was completely inhibited in the presence of the Na ϩ -H ϩ exchanger inhibitor MIA (10 Ϫ5 mol/L) (data not shown). Exposure of cells to Ang II increased Na ϩ -dependent recovery of pH i from an acid load (Figure 6c) . In WKY cells, Ang II caused a 2-fold increase in Na ϩ -dependent recovery of pH i , whereas in SHR, Ang II elicited a 2.8-fold increase in pH i recovery rate (Figure 6c and 6d) . Ang II (10 Ϫ6 mol/L)-induced recovery rate was significantly greater in SHR cells compared with WKY cells (Figure 6d ). These data indicate that Ang II increases activity of the Na ϩ -H ϩ exchanger and that agonist-induced activation is greater in SHR compared with WKY.
Discussion
This study describes a novel transport abnormality in genetically hypertensive rats. In VSMCs from SHR, augmented Ang II-mediated intracellular signaling is associated with increased activation of the Na responses in SHR. These effects may be linked to increased activation of the Na ϩ -H ϩ exchanger. The present study was performed in cells obtained from small mesenteric arteries that contribute to peripheral resistance and consequently to blood pressure regulation. Only primary and first-passage cells that had undergone minimal phenotypic change were used. Although experimental conditions were optimally controlled so that cells from WKY and SHR could be compared, our data are derived from in vitro studies that cannot fully account for the multiple interacting factors and local milieu that cells are exposed to in vivo. Nevertheless, under controlled conditions, Ang II-stimulated responses are altered in cells from SHR, which may be indicative of more complex events in vivo.
Aberrations in Mg 2ϩ metabolism have been implicated in the pathogenesis of essential and experimental hypertension. [1] [2] [3] 46 Decreased [Mg 2ϩ ] i has been reported in many cell types in SHR, [27] [28] [29] [30] and we show here that the magnitude of Ang II-elicited Mg 2ϩ response is greater in SHR than WKY. This could be part of the upregulation of the Ang II signaling pathway in hypertension. 32, 47 Underlying mechanisms for reduced [Mg 2ϩ ] i in hypertension are unclear, but alterations in intracellular Mg 2ϩ regulation may be important. To determine the role of the Na ϩ -dependent Mg 2ϩ transporter in SHR, effects of Ang II were determined in the absence of extracellular Na ϩ and in the presence of quinidine. Although quinidine is not a selective blocker of the Na ϩ -Mg 2ϩ exchanger, it has been extensively used to study this transporter in various cell types. 12, 14, 16, 17, 21, 40 Effects of quinidine appear to be independent of Ca 2ϩ transporters, because quinidine did nor alter [Ca 2ϩ ] i in VSMCs from WKY or SHR (data not shown). In Na ϩ -free conditions and in the presence of quinidine, Ang II-stimulated [Mg 2ϩ ] i responses were inhibited, indicating that the Na ϩ -Mg 2ϩ exchanger plays a major regulatory role in Mg 2ϩ transport and that in SHR it may contribute to altered intracellular Mg 2ϩ homeostasis in both the basal and stimulated states. Our results are in agreement with and extend those of others 46, 48 is also an important regulator of cellular AT 2 receptor expression, which may be increased in cardiovascular diseases. 53 Exact mechanisms that regulate the Na ϩ -Mg 2ϩ exchanger are unclear, but phosphorylation of the Na ϩ -Mg 2ϩ exchanger seems to be a prerequisite for Mg 2ϩ binding to the regulator site. 17 This is analogous to phosphorylation of Na ϩ -H ϩ and Na ϩ -Ca 2ϩ antiporters, which increases the affinity of an 22 To determine whether Ang II activates the Na ϩ -H ϩ exchanger and to assess whether activity of the antiporter is altered in VSMCs from SHR, we measured pH i and activity of the Na ϩ -H ϩ exchanger in response to Ang II. Ang II increased pH i in a dose-dependent manner, with responses significantly higher in SHR than WKY. MIA, at 10 Ϫ6 and 10 Ϫ5 mol/L, completely inhibited Ang II-stimulated alkalinization in WKY and SHR, respectively. Na ϩ -H ϩ exchanger activity in unstimulated cells was higher in SHR compared with WKY, but this was not statistically significant. However, Ang II-induced activation of the exchanger was significantly greater in SHR than WKY. These findings are in agreement with other studies that have demonstrated that Na ϩ -H ϩ exchanger activity is increased in essential and experimental hypertension. 56 -58 Hyperactivation of the exchanger has been attributed to posttranslational regulation in SHR. 59 The Na ϩ -H ϩ exchanger has important effects on vascular smooth muscle growth and contractility, and increased activity of the exchanger has been implicated to play an important role in the development and maintenance of the hypertensive state. 
